Lieven Goeman

709 total citations
24 papers, 313 citations indexed

About

Lieven Goeman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Lieven Goeman has authored 24 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Lieven Goeman's work include Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Prostate Cancer Treatment and Research (6 papers). Lieven Goeman is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Prostate Cancer Treatment and Research (6 papers). Lieven Goeman collaborates with scholars based in Belgium, France and Spain. Lieven Goeman's co-authors include Steven Joniau, Hendrik Van Poppel, Raymond Oyen, Tania Roskams, Laurent Salomon, Jan Pieter Pennings, R. Yiou, Frank Van der Aa, H. Claes and Dimitrios Vordos and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Urology.

In The Last Decade

Lieven Goeman

20 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lieven Goeman Belgium	11	161	74	56	50	49	24	313
Nagahide Matsumura Japan	11	256 1.6×	136 1.8×	43 0.8×	54 1.1×	32 0.7×	30	403
Barbaros Başeskioğlu Türkiye	10	226 1.4×	103 1.4×	38 0.7×	29 0.6×	102 2.1×	37	345
Victoria Y. Bird United States	9	239 1.5×	42 0.6×	26 0.5×	22 0.4×	61 1.2×	18	319
Nima Memaran Germany	9	104 0.6×	49 0.7×	31 0.6×	105 2.1×	62 1.3×	23	389
Gen Kawa Japan	12	152 0.9×	341 4.6×	39 0.7×	67 1.3×	78 1.6×	62	549
Fumimasa Fukuta Japan	13	192 1.2×	146 2.0×	135 2.4×	214 4.3×	56 1.1×	63	512
Meidee Goh United States	7	132 0.8×	41 0.6×	35 0.6×	51 1.0×	109 2.2×	14	336
Jovan Hadži-Djokić Serbia	11	100 0.6×	251 3.4×	39 0.7×	142 2.8×	54 1.1×	89	457
Xiaojian Gu China	11	134 0.8×	25 0.3×	10 0.2×	24 0.5×	75 1.5×	18	310
Hilary A. Rolton United Kingdom	10	113 0.7×	86 1.2×	17 0.3×	8 0.2×	62 1.3×	16	418

Countries citing papers authored by Lieven Goeman

Since Specialization

Citations

This map shows the geographic impact of Lieven Goeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieven Goeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieven Goeman more than expected).

Fields of papers citing papers by Lieven Goeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieven Goeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieven Goeman. The network helps show where Lieven Goeman may publish in the future.

Co-authorship network of co-authors of Lieven Goeman

This figure shows the co-authorship network connecting the top 25 collaborators of Lieven Goeman. A scholar is included among the top collaborators of Lieven Goeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lieven Goeman. Lieven Goeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palou, Juan, M Krawczyński, Lieven Goeman, et al.. (2025). LBA108 Durvalumab (D) in combination with Bacillus Calmette-Guérin (BCG) for BCG-naïve, high-risk non-muscle-invasive bladder cancer (NMIBC): Final analysis of the phase III, open-label, randomised POTOMAC trial. Annals of Oncology. 36. S1650–S1650.

Bertaut, Aurélie, G. Pignot, Nadine Houédé, et al.. (2025). LBA107 ALBAN: A phase III, randomized, open-label, international study of intravenous (iv) atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) vs BCG alone in BCG-naïve high-risk, non-muscle-invasive bladder cancer (NMIBC). Annals of Oncology. 36. S1649–S1650.

Devos, Gaëtan, Lorenzo Tosco, Marcella Baldewijns, et al.. (2025). Final oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 394–394.

Bertaut, Aurélie, L. Corbel, Souhil Lebdai, et al.. (2025). ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC). Annals of Oncology. 37(1). 44–52. 3 indexed citations

Goeman, Lieven, et al.. (2024). Nutritional Supplement With Fermented Soy in Men With an Elevated Risk of Prostate Cancer and Negative Prostate Biopsies: General and Oncological Results From the Prospective PRAECAP Trial. Urology. 188. 131–137. 1 indexed citations

Milenković, Uroš, Eduard Roussel, Gaëtan Devos, et al.. (2023). Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy. European Urology Oncology. 6(6). 582–589. 2 indexed citations

Devos, Gaëtan, Lorenzo Tosco, Marcella Baldewijns, et al.. (2022). ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer. European Urology. 83(6). 508–518. 31 indexed citations

Battaglia, Antonino, Gaëtan Devos, Lieven Goeman, et al.. (2020). Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration. Current Urology. 14(3). 142–149. 5 indexed citations

Goossens, Maria E., Maurice P. Zeegers, Hendrik Van Poppel, et al.. (2016). Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial. European Journal of Cancer. 69. 9–18. 17 indexed citations

10.

Buntinx, Frank, Steven Joniau, Koen Ackaert, et al.. (2012). Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium. BMC Urology. 12(1). 8–8. 13 indexed citations

11.

Joniau, Steven, Lieven Goeman, Tania Roskams, et al.. (2007). Effect of Nutritional Supplement Challenge in Patients with Isolated High-Grade Prostatic Intraepithelial Neoplasia. Urology. 69(6). 1102–1106. 22 indexed citations

12.

Goeman, Lieven, Steven Joniau, Raymond Oyen, & Hendrik Van Poppel. (2006). Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy. Urology. 67(1). 199.e17–199.e19. 32 indexed citations

13.

Goeman, Lieven, Laurent Salomon, Dimitrios Vordos, et al.. (2006). Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients. World Journal of Urology. 24(3). 281–288. 41 indexed citations

14.

Goeman, Lieven, et al.. (2006). Adenocarcinoma of ileal neobladder 20 years after cystectomy. Urology. 68(6). 1343.e9–1343.e10. 9 indexed citations

15.

Joniau, Steven, Lieven Goeman, Jan Pieter Pennings, & Hendrik Van Poppel. (2005). Prostatic Intraepithelial Neoplasia (PIN): Importance and Clinical Management. European Urology. 48(3). 379–385. 28 indexed citations

16.

Joniau, Steven, Lieven Goeman, Guy Bogaert, et al.. (2004). Benign renal mesenchymoma in the pediatric age group: a novel pathologic and karyotype entity. Urology. 63(5). 981–984. 1 indexed citations

17.

Bogaert, Guy, Lieven Goeman, Dirk De Ridder, et al.. (2004). The Physical and Antimicrobial Effects of Microwave Heating and Alcohol Immersion on Catheters that Are Reused for Clean Intermittent Catheterisation. European Urology. 46(5). 641–646. 28 indexed citations

18.

Goeman, Lieven, Steven Joniau, Frank Van der Aa, et al.. (2003). Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?. Prostate Cancer and Prostatic Diseases. 6(4). 305–310. 32 indexed citations

19.

Goeman, Lieven, Steven Joniau, Raymond Oyen, H. Claes, & Hendrik Van Poppel. (2003). Idiopathic Partial Thrombosis of the Corpus Cavernosum: Conservative Management Is Effective and Possible. European Urology. 44(1). 119–123. 31 indexed citations

20.

Goeman, Lieven, Guy Bogaert, Dirk De Ridder, et al.. (2000). The physical and antimicrobial effects of microwaves and alcohol preservation on catheters that are reused for CIC. European Urology. 37(2). 70–70. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact